Drug Approval Package
-
Flolan
(Epoprostenol Sodium) Injection
Company: Glaxo Wellcome, Inc.
Application No.: 20-444/S003
Approval Date: 4/14/2000
-
Approval Letter(s)(PDF)
-
Printed Labeling(PDF)
-
Correspondence(PDF)
Date created: November 20, 2001
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-